The integrin antagonist, cilengitide, is a weak inhibitor of alphaIIbbeta3 mediated platelet activation and inhibits platelet adhesion under flow - Meyer Dos Santos, S; Kuczka, K; Picard-Willems, B (Platelets, 2015)